MLL fusion partners AF4 and AF9 interact at subnuclear foci

被引:0
|
作者
F Erfurth
C S Hemenway
A C de Erkenez
P H Domer
机构
[1] The University of Chicago,Department of Pathology
[2] Tulane University School of Medicine,Department of Pediatrics and the Tulane Cancer Center
来源
Leukemia | 2004年 / 18卷
关键词
MLL; AF4; AF9; acute leukemia; AF4 body;
D O I
暂无
中图分类号
学科分类号
摘要
The MLL gene is involved in translocations associated with both acute lymphoblastic and acute myelogenous leukemia. These translocations fuse MLL with one of over 30 partner genes. Collectively, the MLL partner genes do not share a common structural motif or biochemical function. We have identified a protein interaction between the two most common MLL fusion partners AF4 and AF9. This interaction is restricted to discrete nuclear foci we have named ‘AF4 bodies’. The AF4 body is non-nucleolar and is not coincident with any known nuclear structures we have examined. The AF4–AF9 interaction is maintained by the MLL–AF4 fusion protein, and expression of the MLL–AF4 fusion can alter the subnuclear localization of AF9. In view of other research indicating that other MLL fusion partners also interact with one another, these results suggest that MLL fusion partners may participate in a web of protein interactions with a common functional goal. The disruption of this web of interactions by fusion with MLL may be important to leukemogenesis.
引用
收藏
页码:92 / 102
页数:10
相关论文
共 50 条
  • [21] Interaction of AF4 wildtype and AF4-MLL fusion protein with SIAH proteins: Indication for t(4;11) pathobiology?
    Bursen, A
    Sven, M
    Anne, G
    Theo, D
    Rolf, M
    BLOOD, 2004, 104 (11) : 152B - 152B
  • [22] Mouse Af9 is a controller of embryo patterning, like Mll, whose human homologue fuses with AF9 after chromosomal translocation in leukemia
    Collins, EC
    Appert, A
    Ariza-McNaughton, L
    Pannell, R
    Yamada, Y
    Rabbitts, TH
    MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (20) : 7313 - 7324
  • [23] AF4-AF9 interactions in MLL leukemia
    Nesbit, JB
    Hemenway, CS
    EXPERIMENTAL HEMATOLOGY, 2004, 32 (07) : 64 - 65
  • [24] A homogeneous high-throughput screening assay for inhibitors of the interaction of MLL-AF4 and AF9 in pediatric leukemia
    Drakes, Katherine
    Napper, Andrew D.
    CANCER RESEARCH, 2011, 71
  • [25] The Role of the Intrinsically Disordered and Multifunctional AF9 C-Terminal Domain in MLL-AF9 Leukemia
    Bushweller, John H.
    Leach, Benjamin
    Chang, Ming-jin
    Lumba, Bhavna
    Cierpicki, Tomasz
    Zeleznik-Le, Nancy J.
    Hemenway, Charles S.
    BLOOD, 2011, 118 (21) : 1480 - 1480
  • [26] Structural studies of intrinsically disordered MLL-fusion protein AF9 in complex with peptidomimetic inhibitors
    Yang, Yuting
    Ahmad, Ejaz
    Premkumar, Vidhya
    Liu, Alicen
    Rahman, S. M. Ashikur
    Nikolovska-Coleska, Zaneta
    PROTEIN SCIENCE, 2024, 33 (06)
  • [27] Interaction of AF4 wild-type and AF4. MLL fusion protein with SIAH proteins: indication for t(4;11) pathobiology?
    Bursen, A
    Moritz, S
    Gaussmann, A
    Moritz, S
    Dingermann, T
    Marschalek, R
    ONCOGENE, 2004, 23 (37) : 6237 - 6249
  • [28] The human AF4 and AF4.MLL multiprotein complexes provide functions in transcription and epigenetic processes
    Benedikt, A.
    Baltruschat, S.
    Arrey, T. N.
    Meyer, B.
    Karas, M.
    Bursen, A.
    Dingermann, T.
    Marschalek, R.
    KLINISCHE PADIATRIE, 2009, 221 (03): : 195 - 195
  • [29] No evidence for MLL/AF4 expression in normal cord blood samples
    Trka, J
    Zuna, J
    Hrusak, O
    Michalová, K
    Muziková, K
    Kalinová, M
    Stary, J
    BLOOD, 1999, 93 (03) : 1106 - 1107
  • [30] AF4 and MLL-AF4 are novel targets of MiR-27a in t(4;11) leukemia
    Zanobio, M.
    Fioretti, T.
    Cevenini, A.
    Esposito, G.
    FEBS OPEN BIO, 2018, 8 : 338 - 339